Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biolase Inc
(NQ:
BIOL
)
0.1290
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biolase Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Friday's Intraday Session
January 20, 2023
Via
Benzinga
Dow Rises Over 100 Points; Rayonier Advanced Materials Shares Plunge
January 10, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 100 points on Tuesday. The Dow traded up 0.40% to 33,653.27 while the NASDAQ rose 0.83% to 10,724.37. The S&P...
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 10, 2023
Gainers
Via
Benzinga
Biolase Earnings Perspective: Return On Invested Capital
December 19, 2022
Via
Benzinga
Recap: Biolase Q2 Earnings
August 11, 2022
Biolase (NASDAQ:BIOL) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 10, 2023
Via
Benzinga
Crude Oil Rises Over 1%; Oak Street Health Shares Spike Higher
January 10, 2023
U.S. stocks traded slightly higher midway through trading, with the Dow Jones around than 30 points on Tuesday.
Via
Benzinga
Why BIOLASE Stock Is Getting Hammered During Tuesday's Session
January 10, 2023
BIOLASE Inc (NASDAQ: BIOL) shares are trading lower by 46.25% to $0.37 Tuesday morning after the company announced pricing of a $9.75 million offering.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 09, 2022
Via
Benzinga
Looking Into Biolase's Recent Short Interest
November 28, 2022
Biolase's (NASDAQ:BIOL) short percent of float has risen 16.13% since its last report. The company recently reported that it has 126 thousand shares sold short, which is 1.8% of all regular shares that...
Via
Benzinga
Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday
November 25, 2022
Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 24, 2022
Via
Benzinga
S&P 500 Rises 0.6%; Deere Earnings Beat Estimates
November 23, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 100 points on Wednesday.
Via
Benzinga
Why PagSeguro Digital Shares Are Trading Lower By 18%? Here Are 40 Stocks Moving In Wednesday's Mid-Day Session
November 23, 2022
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) rose 68% to $0.5500 after surging around 87% on Tuesday. Cosmos Holdings recently posted a Q3 loss of $0.08 per share.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 23, 2022
Via
Benzinga
Nasdaq Gains Over 100 Points; Crude Oil Drops Sharply
November 23, 2022
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 21, 2022
Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million.
Via
Benzinga
Biolase Earnings Perspective: Return On Capital Employed
September 06, 2022
Benzinga Pro data, Biolase (NASDAQ:BIOL) reported Q2 sales of $12.23 million. Earnings fell to a loss of $5.61 million, resulting in a 17.48% decrease from last quarter.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022
May 20, 2022
Upgrades
Via
Benzinga
58 Biggest Movers From Yesterday
May 24, 2022
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.
Via
Benzinga
Earnings Preview For Biolase
May 11, 2022
Biolase (NASDAQ:BIOL) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Biolase will report...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 17, 2022
Gainers NeuroOne Medical Tech (NASDAQ:NMTC) shares moved upwards by 12.3% to $3.0 during Thursday's pre-market session. The company's market cap stands at $48.5...
Via
Benzinga
74 Biggest Movers From Yesterday
April 29, 2022
Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 28, 2022
Gainers Enveric Biosciences (NASDAQ:ENVB)...
Via
Benzinga
Earnings Scheduled For March 17, 2022
March 17, 2022
Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 28, 2022
Gainers Provention Bio (NASDAQ:PRVB) shares increased by 16.8% to $3.97 during Friday's pre-market session. The market value of their outstanding shares is at $251.5...
Via
Benzinga
7 of the Best Penny Stocks Under $3 for 2022 to Buy Now
December 31, 2021
Penny stocks under $3 are full of potential and potential pitfalls. These are relatively safe and worth your consideration.
Via
InvestorPlace
41 Stocks Moving In Friday's Mid-Day Session
December 03, 2021
Gainers IO Biotech, Inc. (NASDAQ: IOBT) jumped 42% to $11.74. The company, last month, priced its IPO at $14 per share. Celyad Oncology SA (NASDAQ: CYAD) shares jumped 38.7% to...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 03, 2021
Gainers Celyad Oncology (NASDAQ:CYAD) shares rose 22.75% to $4.37 during Friday's pre-market session. The company's market cap stands at $70.3 million. Biolase (...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.